miles prince, md, on the challenges to recruit and accrue patients to rare-cancer clinical studies
Published 6 years ago • 13 plays • Length 1:16
Download video MP4
Download video MP3
Similar videos
-
1:02
miles prince, md, on the concerns when choosing a treatment plan for newly diagnosed ctcl patients
-
1:43
miles prince, md, discusses i-o compounds and t-cell lymphoma treatment algorithms
-
0:33
miles prince, md, on how ctcl patients will be impacted by treatment with brentuximab vedotin
-
1:55
miles prince, md, discusses the efficacy and safety of brentuximab vedootin to treat ctcl patients
-
1:44
miles prince, md, on which emerging compounds for t-cell lymphomas look promising
-
1:16
miles prince, md, explains the outcomes of the alcanza study in cd30-expressing ctcl
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
7:08
legacy film - a ride to conquer motor neurone disease
-
1:45:04
cmml and other monocytic malignancies - challenges in diagnosis
-
0:52
mike koroscik, mha, shares the scope of the problem with ed visits relating to cancer patients
-
46:30
duke neurology grand rounds: ariel lefland, md - the future (or the lack thereof) of the lecture
-
4:55
professor h miles prince
-
2:13
h. miles prince, md, phd interview part 7
-
0:24
miriam atkins, md, elaborates on what cancer patients can do to advocate for themselves
-
2:58
prof. miles prince | ash 2017 | updated analysis of the alcanza trial
-
1:01
h. miles prince, md, phd interview part 1
-
2:11
h. miles prince, md, phd interview part 2
-
10:50
debate: use of mrd measurements in myeloma - not yet ready for prime time in standard care
-
1:13
mark witte, on mapping cancer patient experience to help influence the design of new cancer centers
-
1:33
michael soulen, md, compares the possible benefits of retrospective vs. prospective trials
-
1:12
mike koroscik, mha, describes strategies that successfully prevent ed visits by cancer patients
-
0:43
h. miles prince, md, phd interview part 6
Clip.africa.com - Privacy-policy